You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 6, June 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (71)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Necrolytic Migratory Erythema

Distinctive Dermatosis of the Glucagonoma Syndrome

Ronald S. Kahan, MD; Maj Rafael A. Perez-Figaredo, MC; Lt Col Andris Neimanis, MC

Arch Dermatol. 1977;113(6):792-797.


Abstract

• Glucagon-secreting tumors of the pancreatic islets (glucagonomas) produce a distinctive syndrome in which weight loss, diabetes mellitus, anemia, and prominent mucocutaneous findings occur. The cutaneous component—necrolytic migratory erythema—may be polymorphous, but most commonly manifests as erosions and crusts of the groin, perineum, buttocks, distal part of the extremities, and central area of the face. Alternatively, scaly papules and plaques may predominate in these areas. The eruption may resemble such dermatoses as pemphigus foliaceus, acrodermatitis enteropathica, chronic mucocutaneous condidiasis, psoriasis, and severe seborrheic dermatitis.

Two patients with chronic, previously undiagnosed dermatoses had necrolytic migratory erythemia, which led to the discovery of glucagonomas present in each. In one patient surgical resection of the tumor resulted in total clearing of the rash within 48 hours. Awareness of this distinctive entity may lead to early diagnosis and, possibly, cure.

(Arch Dermatol 113:792-797, 1977)



Author Affiliations

USAF; USAF

From the Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston.


Footnotes

Accepted for publication Sept 24, 1976.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ultrastructural Studies of Necrolytic Migratory Erythema
Ohyama et al.
Arch Dermatol 1982;118:679-682.
ABSTRACT  

Malignant Glucagonoma Syndrome: Response to Chemotherapy
MARYNICK et al.
ANN INTERN MED 1980;93:453-454.
ABSTRACT  

Necrolytic Migratory Erythema Without Glucagonoma: Report of Two Cases
Goodenberger et al.
Arch Dermatol 1979;115:1429-1432.
ABSTRACT  

Dermatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
DERMATOLOGY COMMITTEE
ANN INTERN MED 1979;91:804-805.
ABSTRACT  

Amino Acid Deficiency and the Skin Rash Associated with Glucagonoma
NORTON et al.
ANN INTERN MED 1979;91:213-215.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.